Won Sik Lee

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Positron Emission Tomography

Acute Lymphoblastic Leukemia

Clinical Practice

Ankylosing Spondylitis

Top Venues

Expert opinion on biological therapy

Leukemia & lymphoma

Yonsei medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jae-Cheol Jo, Youngwoo Jean, DaJung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, Sung Hyun Kim, Keum Young Ahn, TaeHong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)
Jae-Cheol Jo, Young-Woo Jeon, Da Jung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, SungHyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)
Seung Shin Lee, Sung Hoon Jung, Young Rok Do, Dea Sik Kim, Ji Hyun Lee, Han-Seung Park, Joon-Ho Moon, Jun Ho Yi, Yong Park, Young-Il Koh, Ho-Young Yhim, Yun Suk Choi, Yeung Chul Mun, Won Sik Lee, Sung-Eun Lee, Deok Hwan Yang, null null
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Yonsei medical journal 61 (6) (2020)
Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Jung Yong Hong, Deok Hwan Yang, Won Sik Lee, Young Rok Do, Young-Il Koh, Jong-Ho Won, Min-Kyoung Kim, Jae-Cheol Jo, Shin Young Hyun, Jeong A Kim, Young-Ha Oh, Seung Sook Lee
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial). Leukemia & lymphoma 60 (13) (2019)